Results 191 to 200 of about 379,515 (350)

Precision Care for Hereditary Urologic Cancers: Genetic Testing, Counseling, Surveillance, and Therapeutic Implications. [PDF]

Curr Oncol
Somoto T, Utsumi T, Ikeda R, Ishitsuka N, Noro T, Suzuki Y, Iijima S, Sugizaki Y, Oka R, Endo T, Kamiya N, Suzuki H.   +11 more
europepmc   +1 more source

The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms

Henning Reis, Hikmat Al‐Ahmadie, Nadine T. Gaisa, Antonio López-Beltrán, Fiona Maclean, Toyonori Tsuzuki, Isabela W. Cunha, Mahul B. Amin, Jonathan Aning, Manju Aron, Daniel Abensur Athanazio, Richard Bambury, Liang Cheng, Anuradha Gopalan, Christian Gulmann, Charles C. Guo, Carole A. Harris, Gopa Iyer, Rafael E. Jiménez, Masahiro Jinzaki, Eiji Kikuchi, Priti Lal, Kosuke Miyai, George J. Netto, Chin-Chen Pan, Valeria Panebianco, Bas W. van Rhijn, Arlene O. Siefker‐Radtke, Steven C. Smith, Tibor Szarvas, Sara E. Wobker, Glen Kristiansen, Gladell P. Paner   +32 more
openalex   +1 more source

Association of race and 30-day postoperative complications after urologic oncology surgery. [PDF]

Can Urol Assoc J
Bak AB, Pace KJC, Gao B, Wallis CJD, Lee JY.   +4 more
europepmc   +1 more source

Loss of METTL3 m6A methyltransferase results in short‐term progression and poor treatment outcome of bladder cancer patients

International Journal of Cancer, Volume 158, Issue 3, Page 763-774, 1 February 2026.
What's new? Bladder cancer exhibits a highly heterogeneous molecular landscape and treatment response. The dysregulation of RNA modifications such as m6A has been involved in cancer initiation and progression. This study comprehensively analyzed the expression of the main catalytic component of the m6A methylation machinery in bladder tumors across one
Katerina‐Marina Pilala, Stella Koroneou, Maria‐Alexandra Papadimitriou, Konstantina Panoutsopoulou, Konstantinos Soureas, Georgios‐Christos Giagkos, Panagiotis Levis, Dimitrios Linardoutsos, Konstantinos Stravodimos, Margaritis Avgeris, Andreas Scorilas   +10 more
wiley   +1 more source

Readability Optimization of Layperson Summaries in Urological Oncology Clinical Trials: Outcomes from the BRIDGE-AI 8 Study. [PDF]

Curr Oncol
Cano I, Pannu A, Layne E, Ganjavi C, Desai A, Miranda G, Cai J, Magoulianitis V, Gill K, Fuchs G, Desai M, Gill I, Cacciamani GE.   +12 more
europepmc   +1 more source

Diagnostic Value of Micro‐Ultrasound in Identifying Local Recurrence After Radical Prostatectomy

The Prostate, Volume 86, Issue 2, Page 189-195, February 2026.
ABSTRACT Purpose The limited resolution of standard transrectal ultrasound (TRUS) has made it difficult to perform biopsies of the prostate bed in cases of suspected local recurrence following radical prostatectomy. The aim of this study was to benchmark the performance of using high resolution micro‐ultrasound (microUS) in place of standard TRUS for ...
Basil Kaufmann, Manish Choudhary, Ashutosh Maheshwari, Swati Bhardwaj, Adriana Pedraza, Reuben Ben‐David, Asher Mandel, Neeraja Tillu, Vinayak G. Wagaskar, Mani Menon, Michael A. Gorin, Ashutosh K. Tewari   +11 more
wiley   +1 more source

Impact of Diagnosis of Urologic Cancer on Male Sexuality and Patients' Perceptions of Health Professional's Approach. [PDF]

Int Braz J Urol
Barros R, Fosse AM, Schul A, Mangas G, Teixeira CHDS, Ninis T, Carvalho JPM, Favorito LA.   +7 more
europepmc   +1 more source

Short‐Term Longitudinal Changes in Quality of Life Among Japanese Patients With Prostate Cancer After Single‐Port Robot‐Assisted Radical Prostatectomy: A Preliminary Prospective Study

International Journal of Urology, EarlyView.
Takeshi Sasaki, Shinichiro Higashi, Taketomo Nishikawa, Yusuke Sugino, Kouhei Nishikawa, Takahiro Inoue   +5 more
wiley   +1 more source

Mixed Gonadal Dysgenesis: A Comprehensive Review of Clinical Spectrum, Diagnostic Strategies, and Management Approaches

Clinical Endocrinology, Volume 104, Issue 2, Page 92-102, February 2026.
ABSTRACT Background Mixed gonadal dysgenesis (MGD) is a rare form of differences in sex development (DSD) typically associated with 45,X/46,XY mosaicism. The phenotypic presentation of MGD varies from atypical genitalia to typical male or female appearances often associated with Turner stigmata.
Dinesh Giri, Sushil Yewale, Hannah Hickingbotham, Cara Williams, Mohamed Shalaby, Julie Alderson, Julie Park   +6 more
wiley   +1 more source

Socioeconomic disparities in urological cancers in iran: a systematic analysis for the Global Burden of Disease study 2019. [PDF]

BMC Public Health
Khajavi A, Hashemi FH, Khatami F, Ortakand RK, Noori M, Rahimnia R, Aghamir SMK.   +6 more
europepmc   +1 more source